Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
Competitive Landscape of the Testosterone Replacement Therapy Market
The competitive landscape of the testosterone replacement therapy market, with well-known healthcare technology companies, new companies, and telehealth services operating. Within this quickly expanding field, testosterone therapy companies concentrate on coming up with new ideas, combining advanced technology, and building strategic partnerships to improve their therapy strategy and increase their market share. Key players in the market include AbbVie Inc., Bausch Health Companies Inc., Teva Pharmaceutical Industries Ltd., Perrigo Company plc., Cipla Inc., Lupin, Sun Pharmaceuticals Industries Ltd., Hikma Pharmaceuticals PLC, Braeburn Inc., Johnsons & Johnsons Services Inc., Boehringer Ingelheim International GmbH, Allergan, Sun Pharmaceutical Industries Ltd., Sanofi, AstraZeneca, GlaxoSmithKline Plc., Novartis AG, Pfizer Inc., Amneal Pharmaceuticals LLC., and Alvogen.
July 2024: Launch Therapeutics, Inc. and Teva Pharmaceutical Industries Ltd. signed a clinical collaboration deal today to speed up the clinical research program for Teva’s ICS-SABA (TEV-‘248) even more. Teva and Abingworth, a leading international life sciences investment group and a part of the global investment company Carlyle, also announced a strategic development funding agreement today. Under the agreement, Abingworth will give Teva up to $150 million to help pay for its ICS/SABA (TEV-‘248) program. (Source:https://www.tevapharm.com/news-and-media/latest-news/clinical-collaboration-agreement-between-teva-and-launch-therapeutics-to-accelerate-development-of-dual-a/ August 2024: Perrigo Company plc, a major company that makes consumer self-care products, announced that the Women’s National Basketball Association (WNBA) and Opill®, the first daily birth control pill that can be bought without a prescription in the U.S., have formed a multi-year partnership to promote health equity, confidence, and strength, which are all important goals for both groups. (Source:https://www.perrigo.com/media-release/opill-and-wnba-team-groundbreaking-partnership July 2024: Hikma Pharmaceuticals PLC, a global pharmaceutical company, announced an acquisition. The acquisition will include Xellia Pharmaceuticals’ US finished dosage form business and assets, including a commercial portfolio and pipeline of differentiated products, a manufacturing facility in Cleveland, Ohio, sales and marketing capabilities, and an R&D center in Zagreb, Croatia. Xellia Pharmaceuticals is a Copenhagen-based specialty company that specializes in providing anti-infective treatments and other critical care therapies. (Source:https://www.hikma.com/news/hikma-acquires-xellia-s-differentiated-portfolio-and-enhances-injectables-pipeline-manufacturing-capabilities-and-rd/)
Click any bar or cell to request the full company profile
Company
2022 (A)
2023 (A)
2024 (A)
2025 (A)
AbbVie Inc.
•••
•••
•••
•••
Bausch Health Companies Inc.
•••
•••
•••
•••
Teva Pharmaceutical Industries Ltd.
•••
•••
•••
•••
Perrigo Company plc
•••
•••
•••
•••
Cipla Inc.
•••
•••
•••
•••
Lupin
•••
•••
•••
•••
Sun Pharmaceuticals Industries Ltd.
•••
•••
•••
•••
Hikma Pharmaceuticals PLC
•••
•••
•••
•••
Braeburn Inc.
•••
•••
•••
•••
Johnsons & Johnsons Services Inc.
•••
•••
•••
•••
Boehringer Ingelheim International GmbH
•••
•••
•••
•••
Allergan
•••
•••
•••
•••
Sun Pharmaceutical Industries Ltd.
•••
•••
•••
•••
Sanofi
•••
•••
•••
•••
AstraZeneca
•••
•••
•••
•••
GlaxoSmithKline Plc.
•••
•••
•••
•••
Novartis AG
•••
•••
•••
•••
Pfizer Inc.
•••
•••
•••
•••
Amneal Pharmaceuticals LLC.
•••
•••
•••
•••
Alvogen
•••
•••
•••
•••
Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.
According to Cognitive Market Research, the global testosterone replacement therapy market size was USD 2142.6 million in 2024. It will expand at a compound annual growth rate (CAGR) of 4.50% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 857.04 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.7% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 642.78 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 492.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 107.13 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.9% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 42.85 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.
The hospitals held the highest testosterone replacement therapy market revenue share in 2024.
Introduction of the Testosterone Replacement Therapy Market
Testosterone replacement therapy is a medical treatment for men who have low testosterone levels. It raises testosterone levels. The rising incidence of hypogonadism and the naturally lower amounts of testosterone that occur with aging in males are the main forces propelling the testosterone replacement therapy market. In addition, the need for testosterone replacement therapy is being driven by the rising consciousness of the dangers and symptoms linked to low testosterone levels, including exhaustion and lack of muscular mass. In addition to the growing interest in men’s health and fitness, technological developments in therapy also contribute to market growth. As a result, the need for testosterone replacement therapy in injectable product types is expected to rise, contributing to the expansion of the industry.
June 2024: Bausch Health, Canada Inc., a subsidiary of Bausch Health Companies Inc., announced that PrUCERIS aerosol foam, which is used to treat mild to mild distal ulcerative colitis in adults, will be listed on more Canadian public drug plans. (Source:https://ir.bauschhealth.com/news-releases/2024/05-23-2024
Global Testosterone Replacement Therapy Market Analysis Insights Video
Analyst Conclusion
Conclusion
The global testosterone replacement therapy market will expand significantly by 4.50% CAGR between 2024 and 2031.
Injectables in the testosterone replacement therapy market are driven by the fact that they keep testosterone levels more stable, have benefits that last longer, and give accurate doses.
Hospitals drive the testosterone replacement therapy market because of innovative healthcare systems staffed by highly trained medical experts.
Supriya Yadav
Research Analyst · Cognitive Market Research
Supriya is a Team Lead at Cognitive Market Research & Consulting, leading research initiatives and strategic intelligence projects across the Healthcare, Pharmaceuticals, and Medical Devices & Consumables sectors. With more than two years of experience in market research and data analysis, she plays a key role in helping organizations navigate complex healthcare ecosystems, identify emerging opportunities, and make informed business decisions through data-driven insights and market intelligence.
Combining expertise in both primary and secondary research methodologies with a strong academic foundation in Marketing and Finance, Supriya oversees the execution of market assessments, competitive intelligence studies, forecasting models, stakeholder interviews, trend analysis, and custom consulting engagements. She collaborates with healthcare providers, pharmaceutical manufacturers, medical device companies, industry experts, and other key stakeholders to gather firsthand market perspectives while validating findings through extensive research. Her ability to interpret clinical, commercial, and market data enables clients to better understand industry developments, regulatory influences, innovation trends, and competitive dynamics.
In her leadership role, she manages end-to-end research projects and guides cross-functional teams in delivering high-quality market reports, consulting solutions, and strategic studies. Her expertise in market estimation, forecasting, and analytical modeling helps organizations evaluate market potential, assess growth opportunities, strengthen competitive positioning, and support strategic planning initiatives. By transforming complex healthcare and life sciences data into actionable business intelligence, she enables clients to make confident decisions in rapidly evolving market environments.
Driven by a passion for healthcare innovation and continuous professional development, Supriya remains committed to staying ahead of industry trends, technological advancements, and changing market conditions. Her leadership, analytical mindset, and dedication to research excellence help organizations mitigate risks, capitalize on emerging opportunities, and achieve sustainable growth across the global healthcare and life sciences landscape.
The global market size for testosterone replacement therapy in 2024 is USD 2142.6 million.
The global testosterone replacement therapy market is expected to grow with a CAGR of 4.50% over the projected period.
North America held a significant global testosterone replacement therapy market revenue share in 2024.
Asia-Pacific will witness the fastest growth of the global testosterone replacement therapy market over the coming years.
The US had the most significant global testosterone replacement therapy market revenue share in 2024.
The main drivers of the growth of the testosterone replacement therapy market are the increasing age of the male population, growing public interest in men’s health, and new therapeutic possibilities.
The injectables segment had the largest share in the global testosterone replacement therapy market by product type.
★ Reviews
No reviews yet — be the first!
Rate this report
Global Testosterone Replacement Therapy Market Analysis — Table of Contents
Disclaimer: Redacted sample for representative purposes. Charts and data do not depict actual statistics. TOC varies by license selection.
17.6 Future Gross Margin Outlook and Profitability Trends
18.1 Key Takeaways
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study.
You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
18.2 Analyst Point of View
18.3 Assumptions and Acronyms
19.1 Primary Data Collection
19.1.1 Steps for Primary Data Collection
19.1.1.1 Identification of KOL
19.1.2 Backward Integration
19.1.3 Forward Integration
19.1.4 How Primary Research Help Us
19.1.5 Modes of Primary Research
19.2 Secondary Research
19.2.1 How Secondary Research Help Us
19.2.2 Sources of Secondary Research
19.3 Data Validation
19.3.1 Data Triangulation
19.3.2 Top Down & Bottom Up Approach
19.3.3 Cross check KOL Responses with Secondary Data
19.4 Data Representation
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Cognitive Market Research employs "The Full Truth™" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Global Testosterone Replacement Therapy Market Analysis Market analysis.
01
Primary Intelligence Gathering
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
02
Secondary Data Triangulation
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
03
Expert Validation Protocol
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
04
Athenaeum AI Processing
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
05
Editorial & QA Review
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
Latest News about Testosterone Replacement Therapy Market
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Global Testosterone Replacement Therapy Market Analysis market.
Service 01
Market Survey
B2BB2C
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the global testosterone replacement therapy market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
What's Included
Buyer intent & sentiment analysis
Purchase cycle mapping
Price sensitivity research
Channel preference profiling
Competitive perception study
Most Requested
Service 02
Customized Market Data & Reports
CustomReady Report
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
What's Included
Ready syndicate report (250+ pages)
Custom data scope & segmentation
Excel quantitative models
Board-ready PPT with key findings
Secure cloud portal access
Service 03
Strategic Consultation
With SurveyWith Report
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
What's Included
Dedicated analyst assigned to you
Live walkthrough of findings
Strategic Q&A sessions
Go-to-market recommendations
NDA-protected engagement
Customize This Report
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.
